The list below shows The Lymphoma Group's current clinical trials open for recruitment for cutaneous lymphoma patients.
If you would like to know how to access our trials, please see how to contact us.
- RESMAIN - Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.
Suitable for patients who have received treatment and their lymphoma is stable or in remission
- PORT - Phase 2 study testing the use of radiotherapy in addition to pembrolizumab for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma
Suitable for patients with lymphoma which has come back after previous treatment
With special thanks to the following: